West Receives FDA 510(k) Clearance for Vial2Bag Advanced® 13mm Admixture Device
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration systems, today announced FDA 510(k) clearance and launch of its Vial2Bag Advanced® 13mm admixture device. The addition of the Vial2Bag Advanced® 13mm admixture device complements West’s existing…
Kanna Health announces FDA and MHRA approvals to begin its Phase 1 clinical trial for the development of KH-001 as first FDA-approved treatment for premature ejaculation
The US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA) have approved Kanna Health’s Investigational New Drug (IND) application and Clinical Trial Application (CTA), respectively, to start participant enrollment in a Phase 1…
PharmAbcine Receives Safety Review Committee Approval to Advance to Dose Level 2 of Clinical Trial of PMC-403 with Neovascular Age-related Macular Degeneration following Dose Level 1 Safety Data
PharmAbcine, Inc. (“PharmAbcine” or the “Company”) (KOSDAQ: 208340), a clinical-stage public company focused on developing novel antibody therapies for patients, today announced that the Safety Review Committee (SRC) has approved advancing to dose level 2 of the PMC-403 Phase 1 clinical study…
Guidance Statement for Mental Health Symptoms of Long COVID Announced by the American Academy of Physical Medicine and Rehabilitation
Today, the American Academy of Physical Medicine and Rehabilitation (AAPM&R) announced new guidance for diagnosing and treating common mental health symptoms of Long COVID. Long COVID remains a long-term public health issue. Long COVID symptoms are varied, ongoing, and are often…
Vanda Pharmaceuticals to Announce Third Quarter 2023 Financial Results on November 8, 2023
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2023 on Wednesday, November 8, 2023, after the market closes. Vanda will host a conference call at 4:30 PM ET on Wednesday, November 8, 2023, during…
PacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has begun taking orders for its groundbreaking Kinnex RNA kits, which increase throughput for full-length RNA, single-cell RNA, and 16S rRNA sequencing on PacBio’s long-read sequencing systems…
The American Diabetes Association and Genentech Launch a Call to Action for Eye Exams to Prevent Diabetes-Related Vision Loss
The American Diabetes Association® (ADA), a sponsor of the 2023 Magic City Classic (MCC), and Genentech, anchor partner of the ADA’s Health Equity Now® program, launched the Eye Pledge to Fight Diabetes. This program encourages people with diabetes and their loved ones to…
Triumvira Immunologics Announces First Patient Dosed in Phase II of TACTIC-2 Cell Therapy Trial for the Treatment of HER2+ Gastric and GEJ Cancers
Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors, today announced that the first patient has been dosed in Phase II…
Diamond Therapeutics Announces First Patient Enrolled in FDA-authorized Study Evaluating Low-Dose Psilocybin in Human Subjects with Demoralization
Diamond Therapeutics Inc. (“Diamond”), a clinical-stage drug development company focused on non-hallucinogenic, psychedelic-based therapies for use in the treatment of mental health, today announced the enrollment of the first patient in an FDA-approved clinical trial conducted at the University of Alabama…
The Indian Chest Society (ICS) Announces NAPCON 2023
The Indian Chest Society (ICS) is delighted to announce that NAPCON 2023, the most prestigious annual national conference on pulmonary diseases, will be held at Delhi’s Hotel Ashoka Chanakyapuri from Thursday, October 5th, 2023 to Sunday, October 8th, 2023. As…
